22) ferences between CHW-led interventions in low- and middle-income countries (LMICs) a |
23) Health agendas for low- and middle-income countries (LMICs) s |
24) olicy on access to medicines in in non-EU low- and middle-income countries (LMICs), |
25) cant proportion of intracranial masses in low- and middle-income countries (LMICs), |
26) es of ownership increase, particularly in low- and middle-income countries (LMICs). |
27) roportionately impacts patients living in low- and middle-income countries (LMICs). |
28) proportion of existing studies focused on low- and middle-income countries (LMICs). |
29) l settlements (as defined by UN-Habitat), low- and middle-income countries (as defin |
30) However, the evidence from low- and middle-income countries and devel |
31) Many low- and middle-income countries are adopt |
32) e shown that analyses of policy change in low- and middle-income countries are under |
33) rbated, with marginalized populations and low- and middle-income countries burdened |
34) development of the surgical leadership in low- and middle-income countries is key. |
35) aps in the research include evidence from low- and middle-income countries, health o |
36) diabetes mellitus (T2DM) is increasing in low- and middle-income countries, includin |
37) tation methods in informal settlements in low- and middle-income countries.Objective |
38) an important livelihood activity in many low- and middle-income countries. |
39) ANH research addresses inequity issues in low- and middle-income countries. |
40) nt in diseases affecting populations from low- and middle-income countries. |
41) needs of young people living with HIV in low- and middle-income countries. |
42) embers in maternal and child nutrition in low- and middle-income countries. |
43) pment-oriented production of knowledge in low- and middle-income societies. |
44) A further 250 reports of studies in low- and middle-resource countries suggest |
45) nning around home birth in both high- and low- and middle-resource countries. |
46) isk of unfavorable outcomes compared with low- and moderate-risk groups, respectivel |
47) rivers of the purchase and consumption of low- and no-alcohol beers and wines. |
48) Three publications of low- and no-alcohol beers found only limit |
49) Switching from higher strength to low- and no-alcohol products could result |
50) the potential beneficial health impact of low- and no-alcohol products is very limit |
51) onsumers with respect to the labelling of low- and no-alcohol products. |
52) onsumption, and policy drivers related to low- and no-alcohol products. |
53) This work provides a new, low-cost, and effective route to improve t |
54) This work provides a novel, low-cost, and effective way to rationally |
|